Whitehawk Therapeutics, Inc.
David James Lennon (CHIEF EXECUTIVE OFFICER) reports WHWK insider transactions
About this filing
Whitehawk Therapeutics, Inc. (WHWK) filed Form 4 (insider transaction) with the SEC on Sep 15, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- David James Lennon · CHIEF EXECUTIVE OFFICER, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | A · grantStock option (right to buy)Footnotes F1 | +193,957 | $0.00 | $0.00 | 193,957 | Direct |
| Sep 15, 2026 | A · grantRestricted Stock UnitsFootnotes F2, F3 | +193,957 | $0.00 | $0.00 | 193,957 | Direct |
Footnotes
- F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean September 15, 2026.
- F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
- F3 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean September 15, 2026.
More WHWK filings
- 8-K
Filed Nov 9, 2026
- 4/A
Filed Sep 18, 2026
- 4/A
Filed Sep 18, 2026
- 4/A
Filed Sep 18, 2026
- 4/A
Filed Sep 18, 2026
- 4/A
Filed Sep 18, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.